Marker Therapeutics, Inc. Announces Closing of Public Offering of Common Stock
The offering was made pursuant to a shelf registration statement, including a base prospectus, filed by Marker that was declared effective by the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
Investor: Solebury Trout, Brian Korb, (646) 378-2923, email@example.com; Media: Solebury Trout, Amy Bonanno, (914) 450-0349, firstname.lastname@example.org